Arkstone Next is here. Expert-in-the-loop AI clinical intelligence for clinics, urgent care and nursing homes.
See what's new Read the announcementPrecisionASP gives your facilities daily action items, survey readiness and the reports the Centers for Medicare & Medicaid Services (CMS) expects, with infectious disease expertise behind every lab result.
A stewardship program you can show.
See PrecisionASP with your own workflow in a short demo.
PrecisionASP™ reads cultures and antibiotic starts as they happen.
Clear action items for each new start, pending culture and review.
Tracking and the antibiotic use reports CMS expects, kept current.
Infection prevention, staffing and survey prep, often at the same time.
PrecisionASP lists what needs attention today, with the regulation behind each item.
Two residents started antibiotics overnight. Both cultures are tracked to result.
The lab result arrives with a OneChoice report, included at no cost through an Arkstone Qualified Lab. It recommends a narrower antibiotic, with the reasoning, for the care team to review.
The team checks which cases a surveyor is likely to sample and what is missing.
Antibiotic starts per 1,000 resident days, ready for the quality assurance and performance improvement (QAPI) meeting.
Illustrative scenario. Times and details are examples, not a real patient or site.
CMS requires every nursing home to run an antibiotic stewardship program, reviewed in the standard survey.
Source: CMS F881; CDC Core Elements of Antibiotic Stewardship
PrecisionASP is in beta. Features may change before general release.
What PrecisionASP shows when something happens.
Reporting Month · October 2026As of Nov 4, 2026 · 6:00 AM
Cephalexin continued after a resistant urine culture; prescriber not notified.
Four antibiotic starts pass 72 hours today with no time-out recorded.
Active antibiotic orders with no stop date or set duration.
Residents readmitted on a hospital antibiotic with no decision to continue or stop.
Protocols are reviewed at least once a year. The last review was 14 months ago.
The infection prevention and control program (IPCP) is reviewed at least once a year.
Survey Window Open
Last standard survey 13 months ago; the next comes by Dec 9.
Time-Out Audit · Weekly
Monthly ASP Tracking · OctoberBlocked
Census not entered, so the rates cannot be calculated.
Quarterly QAA Meeting
Core Elements Self-Assessment · 2026
State Infection Report · October
IPCP Annual Review
Current care signal
New results and treatment milestones are ordered ahead of acknowledged activity.
Active infection incidents
North wing · Open 3 days
Clinical focus
Latest event
OneChoice recommends oral fosfomycin for this ESBL E. coli cystitis; cephalexin is not expected to be active.
Current regimen
500 mg PO every 12 hours
Time-out due todayShort-stay rehab · Open 4 days
Clinical focus
Latest event
Susceptible to nitrofurantoin. The current 5-day course can stand.
Current regimen
100 mg PO every 12 hours
Last dose tomorrowMemory care · Open 9 days
Clinical focus
Latest event
Confirm the day-10 stop date and the contact precautions plan.
Current regimen
125 mg PO every 6 hours
Review due todaySouth wing · Open 5 days
Clinical focus
Latest event
OneChoice supports oral doxycycline for this MRSA wound infection, with wound care.
Current regimen
100 mg PO every 12 hours
Wound check tomorrowShort-stay rehab · Open 7 days
Clinical focus
Latest event
The course ends after tonight's dose.
Current regimen
1 tablet PO every 12 hours
Last dose todayAs of Nov 4, 2026 · 6:00 AM
October census is incomplete (12 of 31 days), so its rates can’t be calculated.
The last review was 14 months ago. The protocols are reviewed at least annually.
Waiting on the last of three sign-offs before it goes to the committee.
Waiting on approval, so no prescriber has had feedback this quarter.
Reports are held for them until they confirm their address.
PrecisionASP ranks the residents most likely to be reviewed: IV antibiotics, resistant organisms, C. diff and long courses. These are the 3 most likely at Harborview, worst record first.
Bay Unit · Room 12 · Short stay
Cephalexin continued after a resistant result, prescriber not told · The resistant urine culture was not passed to the prescriber, and the same antibiotic continued.
Why a Surveyor Would Pick ThemResistant Culture ResultAntibiotic Not Changed
3 Gaps a Surveyor Would Cite
Garden Unit · Room 7 · Long stay
Hospital IV course continued without review · Started in hospital and continued on readmission with no time-out or stop date.
Why a Surveyor Would Pick ThemIV AntibioticBroad SpectrumHospital Start
3 Gaps a Surveyor Would Cite
East Unit · Room 3 · Long stay
Order has no indication · A suspected urinary infection was treated, but the order does not say what for.
Why a Surveyor Would Pick ThemIndication MissingUrinary Infection
2 Gaps a Surveyor Would Cite
Fictional residents and illustrative data. Decision support, not medical advice.
Why this antibiotic? What changes if the resident is allergic? ARKIE will answer questions about a OneChoice report in plain language. Example questions; the final list comes from the product team.
Outcomes, cost and risk, answered on one page.
Nitrofurantoin (Macrobid) 100 mg PO Q12H × 5 days
For possible uncomplicated UTI
Released by an expert on our clinical team. Delivered by fax, portal or into your EHR.
Example casesFrom Arkstone sample reports. Fictional patients. Decision support only.
Get Started With Your Own Report“The Arkstone Reports provide recommendations and infection control measures that have significantly improved the way we care for patients. It is truly a unique feature that will revamp our antimicrobial stewardship programs.”
Cecilia Arriola‑Wulff, BHCM, LVNRegional Infection Preventionist, AMS OnsiteSee PrecisionASP with your own workflow in a short demo.
